17-63939367-C-CACACATATAT

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_000334.4(SCN4A):​c.*1394_*1403dupATATATGTGT variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.43 ( 15906 hom., cov: 0)
Exomes 𝑓: 0.13 ( 2 hom. )

Consequence

SCN4A
NM_000334.4 3_prime_UTR

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.130
Variant links:
Genes affected
SCN4A (HGNC:10591): (sodium voltage-gated channel alpha subunit 4) Voltage-gated sodium channels are transmembrane glycoprotein complexes composed of a large alpha subunit with 24 transmembrane domains and one or more regulatory beta subunits. They are responsible for the generation and propagation of action potentials in neurons and muscle. This gene encodes one member of the sodium channel alpha subunit gene family. It is expressed in skeletal muscle, and mutations in this gene have been linked to several myotonia and periodic paralysis disorders. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 17-63939367-C-CACACATATAT is Benign according to our data. Variant chr17-63939367-C-CACACATATAT is described in ClinVar as [Benign]. Clinvar id is 324479.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.548 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCN4ANM_000334.4 linkc.*1394_*1403dupATATATGTGT 3_prime_UTR_variant Exon 24 of 24 ENST00000435607.3 NP_000325.4 P35499

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCN4AENST00000435607.3 linkc.*1394_*1403dupATATATGTGT 3_prime_UTR_variant Exon 24 of 24 1 NM_000334.4 ENSP00000396320.1 P35499

Frequencies

GnomAD3 genomes
AF:
0.431
AC:
65261
AN:
151246
Hom.:
15902
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.191
Gnomad AMI
AF:
0.602
Gnomad AMR
AF:
0.440
Gnomad ASJ
AF:
0.557
Gnomad EAS
AF:
0.456
Gnomad SAS
AF:
0.385
Gnomad FIN
AF:
0.523
Gnomad MID
AF:
0.567
Gnomad NFE
AF:
0.553
Gnomad OTH
AF:
0.474
GnomAD4 exome
AF:
0.132
AC:
10
AN:
76
Hom.:
2
Cov.:
0
AF XY:
0.113
AC XY:
7
AN XY:
62
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
4
American (AMR)
AF:
0.00
AC:
0
AN:
4
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AF:
0.250
AC:
1
AN:
4
European-Finnish (FIN)
AF:
0.250
AC:
1
AN:
4
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2
European-Non Finnish (NFE)
AF:
0.148
AC:
8
AN:
54
Other (OTH)
AF:
0.00
AC:
0
AN:
4
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.431
AC:
65289
AN:
151362
Hom.:
15906
Cov.:
0
AF XY:
0.429
AC XY:
31701
AN XY:
73896
show subpopulations
African (AFR)
AF:
0.192
AC:
7932
AN:
41388
American (AMR)
AF:
0.440
AC:
6683
AN:
15204
Ashkenazi Jewish (ASJ)
AF:
0.557
AC:
1926
AN:
3458
East Asian (EAS)
AF:
0.456
AC:
2316
AN:
5084
South Asian (SAS)
AF:
0.385
AC:
1845
AN:
4790
European-Finnish (FIN)
AF:
0.523
AC:
5460
AN:
10434
Middle Eastern (MID)
AF:
0.552
AC:
160
AN:
290
European-Non Finnish (NFE)
AF:
0.553
AC:
37431
AN:
67724
Other (OTH)
AF:
0.476
AC:
999
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1647
3294
4941
6588
8235
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
602
1204
1806
2408
3010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.294
Hom.:
684
Asia WGS
AF:
0.400
AC:
1395
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hypokalemic periodic paralysis Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Paramyotonia congenita of Von Eulenburg Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Congenital Myasthenic Syndrome, Recessive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
May 15, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Familial hyperkalemic periodic paralysis Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Potassium-aggravated myotonia Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.13
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs112489358; hg19: chr17-62016727; COSMIC: COSV104437284; API